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Background: Most people with common mental health problems do not seek evidence-based22
psychological interventions. Aims: The aim of this study was to investigate whether monitoring23
symptoms of depression and anxiety using an app increased treatment-seeking. Method: Three24
hundred and six people with significant levels of anxiety and depression, none of whom were25
currently receiving treatment, were randomly allocated to receive either (a) information about26
local psychological services only, (b) information plus regular symptom monitoring (every 627
days), or (c) information plus open symptom monitoring (monitoring when they felt like it). An28
app was used to provide information and monitor mood. Results: The proportion of participants29
who reported receiving treatment after starting the study was 7.2% (10/138) in the information30
only group, 8.1% (9/111) in the information plus regular monitoring group and 15.8% (9/57)31
in the information plus open monitoring group. There was a trend for participants who were32
able to monitor whenever they wished to be more likely to report receiving treatment than33
people who were only given information about their local treatment services. The impact of the34
intervention was greatest among participants who intended to seek treatment before taking part.35
Limitations were that only a small minority of those who downloaded the app completed the36
study and that the study relied on self-reported measures of treatment-seeking. Conclusions:37
Symptom monitoring can increase actual treatment-seeking in those with an intention to seek38
treatment.39
Keywords: treatment seeking, anxiety, depression, eMental Health, monitoring40
Introduction41
Epidemiological studies have found that one in six people in England suffer from anxiety and/or42
depressive disorders at any point in time (McManus et al., 2009) and these debilitating disorders43
are undertreated (Kessler and Ustun, 2008; Wang et al., 2005). The Adult Psychiatric Morbidity44
Survey in England indicated that only 10% of people with such common mental health problems45
receive psychological interventions (McManus et al., 2009). When psychological therapy is46
received, it is often after long delays, is frequently suboptimal and is not evidence-based47
(Shafran et al., 2009; Wang et al., 2005, 2007). This is despite the fact that people presenting48
with common mental health disorders prefer psychological treatments to medication (Kwan49
et al., 2010; McHugh et al., 2013) and prefer psychological treatments that have more empirical50
support than those that do not (Tarrier et al., 2006).51
One reason why common mental health problems are undertreated is that people often52
do not seek help (McManus et al., 2009). A number of interventions to increase treatment53
receipt and encourage people to seek treatment for common mental health disorders have been54
designed. A systematic review (Gulliver et al., 2012) evaluated these interventions in relation55
to help-seeking intent and help-seeking behaviour. The interventions in the review included56
(1) giving people information to increase mental health literacy, (2) giving people information57
about where to seek treatment, (3) giving people destigmatizing information and (4) giving58
people computerized cognitive behavioural therapy (CBT) with personalized feedback about59
the individual’s symptoms. The review concluded that these interventions had a positive impact60
on intention to seek treatment but little effect on actual treatment seeking, with the exception61
of the computerized CBT intervention (Christensen et al., 2006), which could arguably be62
considered treatment in and of itself.63
Intention to seek treatment is a potential predictor of treatment receipt (Gulliver et al., 2010,64
2012; Schomerus et al., 2009). It is therefore possible that those with high intention to seek65
treatment would benefit from a relatively minor intervention that, according to theoretical66
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models, tips the balance for them to translate intention into action (Ajzen, 1991; Prochaska67
and DiClemente, 1982).68
One potential method to encourage patients to seek treatment is for them to monitor their69
symptoms of anxiety and/or depression, receive feedback about the severity of their symptoms70
and to obtain information on the availability of treatment. Such monitoring of symptoms is71
increasingly common on the internet with a number of freely available applications (NHS72
Choices Reporting Team, 2012).73
Weekly symptom monitoring is effective in improving treatment outcomes when it is74
administered either before or after a treatment session (Kordy et al., 2001; Lambert et al.,75
2003; Lutz et al., 2006). A study by Drake and colleagues investigated the impact of completing76
an online symptom monitoring tool (called Moodscope) daily in people currently receiving77
treatment (Drake et al., 2012). The majority of participants found that the symptom monitoring78
tool helped them manage their symptoms. When interviewed, some participants suggested that79
symptom monitoring might benefit other people experiencing these disorders who were not80
yet willing to see a clinician. However, as of yet the impact of symptom monitoring on seeking81
or receiving treatment is not known.82
The primary aim of this study was to evaluate whether monitoring symptoms of anxiety83
and/or depression increased reported actual receipt of treatment. An application was created84
for Apple iOS devices (iPhone and iPad), called ‘Mood Mate’. A cell phone is an ideal85
medium for monitoring symptoms as it is easily accessible 24 hours a day, and application86
allowed participants to monitor their symptoms of anxiety and depression. As this study is87
the first of its kind, the optimal frequency of monitoring to encourage treatment receipt was88
unknown and it was decided to allocate people to monitoring symptoms every 6 days or open89
monitoring, i.e. whenever the participant chose to. Six-day monitoring was selected because90
psychological treatment sessions are often conducted weekly. As a given day of the week may91
be a confounding factor, it was decided that every 6 days would be optimal. Limiting the use of92
the tool to every 6 days contrasts with tools like Moodscope, which can be completed whenever93
the participant wishes and might be beneficial. To increase ecological validity, participants in94
the open monitoring group were able to monitor whenever they liked.95
Participants were randomized into three groups that were given: (a) information about local96
psychological services only, (b) information plus regular symptom monitoring (every 6 days)97
and (c) information plus open symptom monitoring (monitoring when they chose to). After 3098
days, participants were asked whether they had received treatment since starting the study.99
It was predicted that among people with significant levels of anxiety and depression: (1)100
participants who monitored their symptoms would be more likely to report receiving treatment101
over a 30-day period than participants who only received information about local treatments,102
and (2) monitoring symptoms would have a significant impact on treatment receipt in those103
that already intended to seek treatment. No specific hypothesis was made regarding differences104
between the 6-day and open monitoring groups as this was the first study of its kind.105
Method106
Recruitment107
The application (app) was made available on the iTunes App Store and was on the front page108
for the first week of its release. We used social and traditional media methods of encouraging109
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people to download the app. This included a Twitter Feed, radio interviews and a press release.110
Advertisements focused on the monitoring of mood.111
Participants112
To be eligible to participate in the study participants were required to (1) have an iOS device113
to run the Mood Mate application, (2) be 18 years or older, (3) be based in England, (4) be114
reasonably proficient to read and understand the language of instruction which was English,115
and (5) score above threshold on either the PHQ-4 (Patient Health Questionnaire-4), a four-item116
measure of depression, or the Mini SPIN (Mini Social Phobia Inventory), a three-item screen117
for social anxiety disorder. The thresholds were set at 3 on either the anxiety or depression118
components of the PHQ-4 and 3 on the Mini SPIN, indicating that they were likely to have an119
anxiety or mood disorder (Kroenke et al., 2009; Weeks et al., 2007).120
Participants who met the inclusion criteria on the screening and stated that they were already121
receiving treatment at the time of the study were included in the study but excluded from the122
analysis (n = 1952, 22.5%). The mean age of the 306 participants who remained in the analysis123
was 27.2 years old (SD = 9.7). The majority of participants were female (n = 217, 70.9%)124
and a large proportion of the sample had never received treatment (n = 228, 74.5%). The125
majority of participants were Caucasian (n = 256, 83.7%), 9.5% (n = 29) were Asian, 2.3%126
(n = 7) were Mixed Race, 2.3% (n = 7) were Black and 2.3% (n = 7) of participants stated that127
they were of an ‘other’ ethnicity, or did not wish to divulge their ethnicity. Sixty-two (20.3%)128
participants did not meet the threshold on the PHQ-4, but did score above the threshold on the129
Mini SPIN.130
Procedure131
Once participants downloaded the app they were shown information about the study and were132
screened with the Patient Health Questionnaire-4 (PHQ-4) which consists of the first two items133
of the PHQ-9 (referred to as the PHQ-2) and the first two items of the GAD-7 (see below).134
If potential participants scored below the threshold on the PHQ-4, which does not screen135
avoidance behaviours, they were asked to complete the Mini Social Phobia Inventory (Mini136
SPIN) to detect social anxiety. If participants scored below the threshold on both measures137
they were signposted to a helpline where they could receive support if they wanted it and they138
did not continue with the study.139
Those participants who scored above the threshold on either screening measure were140
presented with a consent form. Participants who consented were then given the baseline141
questionnaire to establish their baseline characteristics. They were then automatically142
randomized by the application using a built-in random number generator into either the control143
group or one of two monitoring groups. Participants in the control group received information144
about common mental health conditions and possible treatments. They were informed of the145
location and contact details of all Improving Access to Psychological Therapy (IAPT) services146
in England including their websites. These are psychological treatment services for anxiety147
and depression, the majority of which accept self-referrals. The location of the closest IAPT148
service to the participant could be found using the global positioning system (GPS) location149
of their iPhone.150
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Participants in the monitoring groups received the same information as the control group.151
Additionally they were asked to monitor their anxiety and depression symptoms by completing152
the Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001) and the Generalized Anxiety153
Disorder Assessment (GAD-7; Spitzer et al., 2006). Those in the 6-day monitoring group were154
asked to monitor their symptoms every 6 days, while those in the open monitoring group were155
able to monitor their symptoms as often as they wished. Both groups were sent reminders to156
monitor their symptoms every 6 days to ensure that all participants received the same number157
of reminders.158
Participants in the monitoring groups could view their scores on the PHQ-9 and GAD-7159
measures graphically over time whenever they accessed the app. Participants were informed160
of the clinical thresholds for both measures, so they could understand where their symptoms161
placed them with respect tp mild, moderate, moderately severe and severe depression on the162
PHQ-9 and mild, moderate and severe anxiety on the GAD-7.163
All participants were asked to not delete the app before completing the post-intervention164
measure, which was administered after 30 days of app use. After completing the post-165
intervention measure, participants in the control group were offered the opportunity to use166
the application’s symptom monitoring tools that had been accessible to participants in the167
experimental groups. All communication with participants was via the app only. In nine cases168
participants emailed the authors to state that the contact details of IAPT sites were not correct.169
These were corrected within 48 hours.170
Measures and materials171
Mood Mate. The app was developed by J.R., A.G. and S.A. and was free for participants172
to download onto iPhones. This app was purely developed as a research tool and had no173
commercial interest. An earlier prototype of the application was shown to focus groups174
consisting of service users in the local area, to ensure that it met the needs of potential175
participants. The app was available to download on the UK iTunes store from 10 October176
2012 until 9 April 2013 and was promoted via blogs, radio and Twitter.177
The Patient Health Questionnaire-4 (PHQ-4; Löwe et al., 2010). The PHQ-4 consists of178
the first two items of the PHQ-9 (referred to as the PHQ-2) and the first two items of the179
GAD-7 (referred to as the GAD-2). It is a screening tool for low mood and anxiety, rather180
than a validated diagnostic tool. The PHQ-4 has been studied in the general population and in181
Primary Care, with high scores on the measure being found to be associated with functional182
impairment, disability days, and healthcare use (Kroenke et al., 2009; Löwe et al., 2010). The183
threshold used in this study was a score of 3 or above on the PHQ-2 and/or the GAD-2, so all184
participants were likely to have at least mild anxiety and/or depression. Scores range from 0185
to 12 and are categorized as normal (0–2), mild (3–5), moderate (6–8) and severe (9–12).186
The Mini Social Phobia Inventory (Mini SPIN; Connor et al., 2001). The Mini SPIN is a187
reliable and valid three-item instrument for screening social anxiety disorder in adults (Seeley-188
Wait et al., 2009; Weeks et al., 2007). To be included in the study, participants had to score 3189
or above, as a liberal screening tool for social phobia. Scores range from 0 to 12 and are not190
categorized into severity groups.191
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The Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001). The PHQ-9 is a self-192
administered nine-item questionnaire developed to measure low mood. The PHQ-9 has a193
sensitivity of 88% and a specificity of 88% for major depression (Kroenke et al., 2001). Scores194
range from 0 to 27 and are categorized into: healthy (0–5), mild (5–9), moderate (10–14),195
moderately severe (15–19) and severe (20–27).196
The Generalized Anxiety Disorder Assessment (GAD-7; Spitzer et al., 2006). The GAD-7197
is a self-administered seven-item questionnaire developed to screen for GAD. It has also been198
shown as a valid measure of anxious symptomatology across all anxiety disorders using a199
cut-off of 8 or greater (sensitivity 77%, specificity 82%) (Kroenke et al., 2007). Scores range200
from 0 to 21 and are categorized into: healthy (0–4), mild (5–9), moderate (10–14) and severe201
(15–21).202
Baseline measure. Participants were asked eight questions which assessed: gender (binary203
choice), birth year, ethnicity (applying the 16 categories used by the Office of National204
Statistics), whether they had ever sought treatment for, and whether they had ever received205
treatment for, a mental health condition (binary choices). Current treatment-seeking intention206
for a mental health issue, how effective they believed psychological therapies were in207
treating common mental health disorders and how effective they believed medication was208
in treating common mental health disorders were assessed using a 0–100 point analogue scale,209
administered with sliders.210
Post-measure. The outcome measure was designed to determine whether or not a211
participant had sought and/or received any treatment for a mental health condition since212
starting the study (binary choice). If participants indicated that they had received mental213
health treatment since starting the study, they were asked what their diagnosis was (if they214
were given one), what treatment they received and from whom they received treatment. These215
three items were assessed using multiple-choice questions with the possibility to respond216
in an open text box. Participants were also asked to re-asses how effective they believed217
psychological therapies were in treating common mental health disorders and how effective218
they believed medication was in treating common mental health disorders, assessed with 0–100219
point analogue scale, administered with sliders.220
Data analysis plan221
To assess whether there were any differences between participants who completed the outcome222
measures and those who did not, a logistic regression was used. Participants were compared223
on the basis of their PHQ-4 severity, gender, age, ethnicity, previous receipt of treatment, prior224
intention to seek treatment and belief in the effectiveness of psychological and pharmacological225
treatments.226
To assess whether there were any differences between the three groups, the characteristics227
of the participants were compared using Kruskal–Wallis tests for continuous variables (PHQ-4228
severity, age, prior intention to seek treatment, belief in the effectiveness of psychological229
and pharmacological treatments) and Chi-squared analyses for categorical variables (gender,230
ethnicity, previous receipt of treatment). As eight tests were performed, a Bonferroni correction231
was used to adjust p values.232
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Figure 1. CONSORT diagram showing participant flow in the Mood Mate study
The primary outcome measure was reported receipt of treatment in the 30 days since starting233
the study. Two dummy variables coding participants’ groups were used, with the information-234
only group acting as the reference group. Lemeshow and Hosmer’s goodness of fit test was235
used to assess the fit of the models, and all models were shown to fit the data well (p > .05)236
(Lemeshow and Hosmer, 1982). Effect sizes are expressed as odds ratios (OR) and confidence237
intervals are reported. All analyses were conducted using SPSS v19.238
Power analyses239
Power analyses were conducted using G*Power 3.1 (Faul et al., 2007). A sample of 160 was240
needed to find a medium effect when comparing either of the monitoring groups with the241
control group, assuming equally balanced groups.242
Results243
Figure 1 shows the flow of participants through the study. Participants who were receiving244
treatment at the start of the study were excluded from the analysis which is why 8997 met the245
clinical threshold and were therefore given access to the tool, but only 6725 were included246
in the analysis. Furthermore, given the vast number of participants randomized but the small247
number of post-measures completed, it was decided that a completer analysis, rather than an248
intent-to-treat analysis, would be performed. Of the 8997 people that were randomized, 306249
participants completed the post-measure.250
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Table 1. Baseline descriptive statistics of the participants in the three conditions and results of the
comparisons between the groups
Control group 6-day monitoring Open monitoring χ2 Adjusted
Variable (n = 138) group (n = 111) group (n = 57) (d.f.) p value
PHQ-4 score (SD) 6.34 (2.68) 6.37 (2.76) 6.09 (2.85) 0.53 (2) 1
Age (SD) 26.57 (9.61) 27.85 (9.81) 27.23 (9.72) 1.01 (2) 1
Female n (%) 94 (68.12%) 84 (75.68%) 110 (68.42%) 1.92 (2) 1
Ethnicity n (%) 8.23 (8) 1
White 113 (81.88%) 98 (88.29%) 45 (78.95%)
Mixed 3 (2.17%) 1 (0.90%) 3 (5.26%)
Asian 16 (11.6%) 8 (7.21%) 5 (8.77%)
Black 3 (2.17%) 3 (2.70%) 1 (1.75%)
Other or unknown 3 (2.17%) 1 (0.90%) 3 (5.26%)
Intention to seek
treatment (SD)
29.07 (29.17) 34.52 (33.67) 30.70 (31.00) 0.91 (2) 1
Belief in the
effectiveness of
psychotherapy (SD)
57.58 (24.05) 54.24 (29.63) 49.86 (28.22) 2.61 (2) 1
Belief in the
effectiveness of
medication (SD)
44.38 (25.87) 41.68 (29.98) 38.81 (25.61) 1.79 (2) 1
Received treatment
before n (%)
28 (20.29%) 38 (34.23%) 12 (22.05%) 7.02 (2) .240
To investigate whether there was a difference between those who completed the post-251
measure and those who did not, logistic regression was performed. The model found that the252
baseline characteristics of participants described in Table 1 did not predict whether participants253
completed the outcome measure battery [χ ²(11) = 9.79, p = .550]. The model explained 0.5%254
in variance between the participants who completed the outcome measure and those who did255
not. The descriptive statistics are shown in Table 2.256
At baseline the mean score for all participants on the PHQ-4 was 6.30 (SD = 2.74); 6.21%257
were classed as normal on this measure (n = 19), 35.29% were mild (n = 108), 33.66% were258
moderate (n = 103) and 24.84% were severe (n = 76). The mean score on the Mini SPIN259
was 5.69 (SD = 2.08). Characteristics of the participants by group are shown in Table 1 along260
with the results of the Kruskal–Wallis tests and Chi-squared comparisons between the groups.261
These found no significant differences between the groups.262
Effect of symptom monitoring on treatment receipt263
The proportion of participants who reported receiving treatment after starting the study was264
7.2% (10/138) in the control group, 8.1% (9/111) in the 6-day monitoring group and 15.8%265
(9/57) in the open monitoring group. Overall, 9.2% (28/306) of the participants started new266
treatment during the 30-day period.267
Logistic regression found no significant difference between the proportion of people who268
reported receiving treatment in the control group and the 6-day monitoring group (OR = 1.13,269
Symptom monitoring and treatment seeking 9
Table 2. Baseline characteristics of participants who completed the outcome measure and those that did
not
Did not complete outcome Completed outcome
Variable measure (n = 6419) measure (n = 306)
PHQ-4 score (SD) 6.43 (2.87) 6.30 (2.74)
Age (SD) 26.83 (9.26) 27.16 (9.69)
Female n (%) 4302 (67.0%) 217 (70.9%)
Ethnicity n (%)
White 5344 (83.3%) 256 (83.7%)
Mixed 261 (4.1%) 7 (2.3%)
Asian 489 (7.6%) 29 (9.5%)
Black 159 (2.5%) 7 (2.3%)
Other or unknown 166 (2.6%) 7 (2.3%)
Intention to seek treatment (SD) 32.79 (31.96) 31.35 (31.20)
Belief in the effectiveness of
psychotherapy (SD)
55.25 (28.27) 54.93 (27.03)
Belief in the effectiveness of
medication (SD)
43.84 (28.19) 42.36 (27.38)
Received treatment before n (%) 1727 (26.9%) 78 (25.5%)
p = .799, 95% lower CI = 0.44, 95% upper CI = 2.88). However, there was a trend for people270
who were in the open monitoring group to be more likely to report receiving treatment than the271
control group (OR = 2.40, p = .074, 95% lower CI = 0.92, 95% upper CI = 6.27). Overall,272
this model was not found to be significantly better at predicting whether or not participants273
received treatment than a model that just contained the constant [χ ²(2) = 3.33, p = .189] and274
only 2.4% of the variance in treatment receipt was explained, using Nagelkerke’s R2.275
Post-hoc analysis on the role of intention to seek treatment276
As the previous analysis did not find a significant difference between groups, post-hoc analyses277
were undertaken to investigate whether intention to seek treatment had a moderating role278
between symptom monitoring and treatment receipt. In order to investigate whether the impact279
of symptom monitoring was greater among those who had high intention to seek treatment, a280
median split was used to differentiate between participants who had low versus high intention281
to seek treatment at baseline.282
Among those with low intention to seek treatment, people in the 6-day and open monitoring283
groups were no more likely to report treatment receipt than the control group (OR = 0.65,284
p = .628, 95% lower CI = 0.12, upper CI = 3.69; and OR = 1.15, p = .876, 95% lower285
CI = 0.20, upper CI = 6.62, respectively). Overall, this model was not found to be significantly286
better at predicting whether or not participants received treatment than a model that just287
contained the constant [χ ²(2) = 0.35, p = .839]. Nagelkerke’s R2 indicated that only 0.7% of288
the variance in treatment receipt was explained.289
Among participants who stated that their intention to seek treatment was above or equal to290
the median score, people in the 6-day monitoring group were no more likely to report treatment291
receipt than the control group (OR = 1.41, p = .564, 95% lower CI = 0.44, upper CI = 4.46).292
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However, the open monitoring group was significantly more likely to report receiving treatment293
than the control group (OR = 3.82, p = .030, 95% lower CI = 1.14, upper CI = 12.84). Overall,294
this model was not found to be much better at predicting whether or not participants were more295
likely to receive treatment than a model that just contains the constant, but a trend was found296
[χ ²(2) = 4.78, p = .092]. Nagelkerke’s R2 indicated that 5.8% of the variance in treatment297
receipt was explained.298
Type of treatment sought299
Twenty-eight participants reported receiving treatment at the end of the study. For the majority300
of these participants treatment was received from their general practitioner (75.0%, n = 21),301
with one participant (3.6%) receiving treatment from an IAPT site and two (7.1%) receiving302
treatment from a private therapist. Four participants (14.2%) did not state from whom they303
received treatment.304
Of the 28 participants who reported receiving treatment, 12 (42.9%) reported receiving a305
psychological treatment, nine (32.1%) reported receiving medication, two (7.1%) reported306
receiving both a psychological therapy and medication, and five (17.9%) reported an307
unclassified type of treatment. Of those who received psychological therapies eight received308
counselling (57.1%), five received CBT (35.7%) and one received psychodynamic therapy309
(7.1%).310
For the 28 participants who reported receiving treatment, four were diagnosed with311
depression (14.2%), three with mixed anxiety and depression (10.7%), one with social phobia312
(3.6%) and one with post-traumatic stress disorder (3.6%). However, the majority either did313
not receive a diagnosis or stated they were not sure (n = 15, 53.5%). Two stated family loss314
(7.1%) and one preferred not to disclose the diagnosis (3.6%).315
Discussion316
This study investigated the effect of monitoring symptoms on treatment receipt. The proportion317
of participants who reported receiving treatment after starting the study was 7.2% (10/138)318
in the information group, 8.1% (9/111) in the 6-day monitoring group and 15.8% (9/57) in319
the open monitoring group. Half of the participants who reported receiving treatment received320
psychological treatments, but it was unclear whether these were evidence based. Among those321
that completed the final survey, participants who were able to monitor whenever they wished322
were more likely to report receiving treatment than people who were only given information323
about their local treatment services or were limited to using the app once every 6 days. The324
impact of the intervention was greatest among participants who intended to seek treatment325
before taking part in the study, consistent with the Transtheoretical Model of Change (Prochaska326
and DiClemente, 1982).327
This study indicates that monitoring symptoms for people with a high intention to seek328
treatment might translate that intention into actual treatment-seeking behaviour, but if the329
effect exists, it is small. Previous research indicates that most people with common mental330
health disorders do not seek treatment, and those that do often wait a long time before331
doing so (McManus et al., 2009; Wang et al., 2007). Delaying treatment can lead to negative332
consequences for those with anxiety and depression (Brenes, 2007; Hawton and van Heeringen,333
2009). Therefore, simple interventions to reduce the time it takes for people with anxiety and334
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depression to receive treatment are of potential value. The result of the current study leads some335
support to the notion that interventions may be more effective if targeted at an individual’s336
current situation (Noar et al., 2007).337
The majority of participants who received psychological treatments stated that they received338
counselling. Counselling is one of the NICE-recommended treatments for depression (NICE,339
2011), but it is not recommended by NICE for any other mental health disorder. As the majority340
of participants did not report having received a diagnosis it is unclear whether the treatment341
they were given was evidence based. Further work should focus on whether an intervention342
can encourage people to receive treatments that are recommended by NICE, as opposed to343
another type of psychological treatment.344
This study was not the first to trial an intervention to increase the number of people seeking345
or receiving treatment for anxiety and depression (Christensen et al., 2006). However, most346
interventions that have previously attempted to increase treatment receipt have only increased347
people’s intention to seek treatment, rather than their behaviour (Gulliver et al., 2012). As348
the aim of these interventions has been to change the antecedents to behaviour, the effects349
on actual behaviour have frequently not been reported (Gulliver et al., 2012). The distinction350
between intention and behaviour is important for future behaviour change research. In this351
study, symptom monitoring was found to moderate the relationship between intention to seek352
treatment and treatment receipt. Rather than trying to change the antecedents of behaviour,353
interventions should also aim to increase the likelihood of intention being converted into354
action and future behaviour change research should consider the relationship between these355
two distinct constructs.356
This study is subject to a number of limitations. Given the small number of people357
who completed the post-measure, it might be possible that this study’s findings cannot be358
generalized to the wider population. Comparisons between the baseline characteristics of359
the groups indicate that there were no observed systematic differences between those who360
completed the post-measure and those who did not. It may also be the case that the effect361
of the intervention on treatment receipt may be a statistical artefact – the absolute numbers362
of people that reported receiving treatment were very similar. Analyses were undertaken to363
test whether or not participants who completed the outcome measure differed significantly on364
the measured variables by group. This was done to ascertain whether the differential drop-out365
rates had biased the analyses. There were no systematic differences between the groups on the366
measured variables, but this does not rule out the possibility of there being systematic biases367
between the groups on unmeasured variables. It is interesting that approximately twice as368
many participants completed the post-measure in the control and the 6-day monitoring group369
compared with the open monitoring group. It may be the case that continually having access to370
monitoring symptoms makes participants less inclined to complete post-measures. The high371
drop-out rate in this study also led to the analyses being less powerful than predicted, given the372
large initial sample size. High drop-out rates are common in eHealth trials – even up to 99.5%373
(see Eysenbach, 2005) – and thus the rate observed in this trial is not considered anomalous.374
The design of the application may have impacted the length of time it was used by people.375
A number of authors have proposed certain design principles that have an impact on the length376
of time a user engages with an application (Fogg and Eckles, 2007). However, these design377
principles are rarely tested prospectively and robustly evaluated (Manzi, 2012) For this reason,378
further robust evaluation of the design of applications in relation to their effects on behaviour379
change should be undertaken.380
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This study did not collect information on suicidality in response to ethical concerns that if381
we were made aware of suicidality, we would be required to act. In order to act, we would have382
been required to identify individuals and monitor their responses. Given the nature of this study,383
it was not feasible to do so and we therefore omitted questions on suicidality for ethical reasons384
although such issues should be considered in future studies. Similarly it would be helpful for385
future studies to collect information on how often participants in the opening monitoring group386
monitored their symptoms and the monitoring behaviour of participants that did not complete387
the study. In addition, it is important to note that the timeframe of 30 days of monitoring was388
relatively arbitrary. It was chosen as it was considered that it would maximize engagement389
with the app and was sufficient to see fluctuations in mental health symptoms. However, it390
may have been too short to allow the full range of fluctuations to be captured and it was also391
inconsistent with the timeframe for the self-report measures of anxiety and depression which392
have a 2-week timeframe. Furthermore, the high drop-out rate would indicate a shorter period393
might be better for engagement and modifying the monitoring in some ways, for example394
personalizing messages and reminders, might also be beneficial for retention.395
A further limitation is the study’s dependency on the self-reported post-measures that are396
not diagnostic. As treatments were self-reported by the participants it is impossible to verify397
whether or not treatments actually took place. We specifically chose the wording of the question398
to reflect whether or not the participant reported receiving treatment instead of asking whether399
participants had sought treatment as we assumed there would be greater ambiguity about what400
behaviours can be considered as ‘seeking’ treatment. It is acknowledged that by wording the401
question in this way, participants who had sought treatment but were on a waiting list at time402
of study end would not be counted as having received treatment.403
Future versions of this study could include the PHQ-9 and GAD-7 in the baseline and post-404
measure. This would allow us to establish whether symptom monitoring had an impact on405
participants’ symptoms of anxiety or depression among participants who received treatment406
while using the application and those who did not. The work by Lambert and colleagues would407
suggest that participants who received psychotherapy and monitored their symptoms would408
have better outcomes than participants who received psychotherapy and do not monitor their409
symptoms (Kordy et al., 2001; Lambert, 2007, 2013; Lambert et al., 2003; Lutz et al., 2006).410
The findings from this study indicate that symptom monitoring can encourage those who411
already have a high intention to seek treatment to actually seek it, provided that they are able412
to monitor their symptoms whenever they see fit. More generally, this study shows that cell413
phone applications can be used as a platform to run a randomized field trial, although high414
levels of drop-out are to be expected.415
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